Skip to main content
Wendy Stock, MD, Oncology, Chicago, IL

Wendy Stock MD

Hematologic Oncology


Professor of Medicine, University of Chicago Medicine

Join to view full profile
  • 5841 S Maryland AveChicago, IL 60637

  • Phone+1 888-824-0200

  • Fax+1 773-834-0778

Dr. Stock is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1989 - 1993
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1985 - 1988
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1985

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1987 - 2029
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic Leukaemia  
    Michael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature

Abstracts/Posters

  • Outcomes of IDH-Mutated Advanced Phase Ph-Negative Myeloproliferative Neoplasms Treated with IDH Inhibitors
    Wendy Stock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • CXCR4 Inhibition with BL-8040 in Combination with Nelarabine in Patients with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia / Lymphoblastic Lymphoma
    Wendy Stock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Feasibility and Outcomes of T-Cell Depleted Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML and High Risk MDS
    Wendy Stock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Adult Clinical Malignant Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • New Data and Paradigms in ALL: Insights and Applications 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Adult Clinical Malignant Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Other

Press Mentions

  • TBI-Free Conditioning Before Transplant Effective in MRD-Negative B-ALL
    TBI-Free Conditioning Before Transplant Effective in MRD-Negative B-ALLDecember 7th, 2025
  • Potential Game-Changing Impact on Mismatched Unrelated Blood Cell Transplantation
    Potential Game-Changing Impact on Mismatched Unrelated Blood Cell TransplantationDecember 7th, 2025
  • Advances in Technology Help Improve Safety and Access to Blood Cancer Therapies
    Advances in Technology Help Improve Safety and Access to Blood Cancer TherapiesDecember 6th, 2025

Grant Support

  • Program 2 (Molecular Genetics And Hematopoiesis)National Cancer Institute2008–2012

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: